期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 79, 期 16, 页码 1549-1561出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.01.053
关键词
heart failure; left atrium; speckle tracking
资金
- National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]
- Actelion
- Alnylam
- Amgen
- AstraZeneca
- Bellerophon
- Bayer
- BMS
- Celladon
- Cytokinetics
- Eidos
- Gilead
- GSK
- Ionis
- Lilly
- Mesoblast
- MyoKardia
- NIH/NHLBI
- Neurotronik
- Novartis
- NovoNordisk
- Respicardia
- Sanofi Pasteur
- Theracos
- US2.AI
- [R01 HL126637]
- [K24 HL155813]
- [R01 HL141288]
This study assessed the left atrial (LA) structure and function in older adults without prevalent heart failure (HF) and found that LA measures were associated with NT-proBNP and increased risk of incident HF or death. These measures, when added to traditional risk factors and NT-proBNP, improved the accuracy of predicting cardiovascular events.
BACKGROUND Limited data exist to characterize novel measures of left atrial (LA) structure and function in older adults without prevalent heart failure (HF). OBJECTIVES The aim was to assess reference range of LA measures, their associations with N-terminal pro-B-type natriuretic-peptide (NT-proBNP) and the related risk for incident HF or death. METHODS We analyzed LA structure (LA maximal [LAViMax] and minimal volume indexed by body surface area) and function (LA emptying fraction, LA reservoir, conduit, and contraction strain) in 4,901 participants from the ARIC (Atherosclerosis Risk In Communities) study (mean age 75 +/- 5 years, 40% male, and 19% Black) without prevalent HF. We assessed sex-specific 10th and 90th percentile ARIC-based reference limits in 301 participants free of prevalent cardiovascular disease, and related LA measures to NT-proBNP and incident HF or death (median follow-up of 5.5 years) in the whole ARIC cohort. RESULTS Approximately 20% of the overall population had LA abnormalities according to the ARIC-based reference limit. Each LA measure was associated with NT-proBNP and, except for LAViMax, with incident HF or death after multivariable adjustment (including left ventricular function and NT-proBNP). Results were consistent in participants with normal LAViMax (P for interaction > 0.05). LA measures were prognostic for both incident HF with preserved ejection fraction or death and incident HF with reduced ejection fraction or death. When added to HF risk factors and NT-proBNP (baseline C-statistics = 0.74) all LA measures, except for LAViMax, significantly enhanced the prognostic accuracy. CONCLUSIONS Novel measures of LA structure and function, but not standard assessment by LAViMax, are associated with increased risk of incident HF or death regardless of measures of left ventricular function and NT-proBNP. (C) 2022 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据